The Central Drugs Standard Control Organisation (CDSCO) has issued a landmark ruling that bans cosmetic injections, redefining them as drugs rather than cosmetics. This decision is set to reshape the market for easy-to-buy weight loss jabs, including popular brands like Ozempic and Wegovy.
What the CDSCO Ruling Means
According to the CDSCO, cosmetics are only intended to be rubbed, poured, sprinkled, or sprayed on the human body. Injectable products, therefore, fall outside this definition and must be regulated as drugs under the Drugs and Cosmetics Act. This change brings stricter oversight on manufacturing, sale, and distribution of such products.
Impact on Weight Loss Jabs
Weight loss injections, which have gained immense popularity in recent years, are now subject to the same rigorous standards as prescription medications. Previously available through loose regulations, these jabs will now require proper medical prescription and monitoring. The ban on cosmetic injections aims to curb misuse and ensure patient safety.
Industry and Consumer Reactions
Industry experts anticipate a significant shift in the market. Pharmaceutical companies may need to relabel products and seek fresh approvals. Consumers, meanwhile, will face stricter access, potentially reducing the risk of adverse effects. The CDSCO's move aligns with global trends to tighten control over injectable weight loss aids.
Background and Enforcement
The Drugs and Cosmetics Act, 1940, governs the import, manufacture, and sale of drugs and cosmetics in India. By classifying injectables as drugs, the CDSCO empowers itself to enforce quality standards, clinical trial requirements, and post-market surveillance. Violations could lead to penalties, including product seizures and legal action.
This ruling follows growing concerns over the unregulated sale of weight loss jabs, often marketed as cosmetic treatments. The CDSCO's decision clarifies the legal status of such products, ensuring they meet safety and efficacy benchmarks.
Looking Ahead
The ban is expected to take immediate effect. Stakeholders, including clinics and online sellers, must comply or face consequences. For patients, the change promises safer access to weight loss treatments under medical supervision. The CDSCO continues to monitor the situation and may issue further guidelines.
